Lots of coverage in the Irish newspapers about the phrama sector at the weekend. Particular focus on ‘branded’ pharma V `generic’ pharma. Two things occur. One is that many companies do both. Secondly, Ireland is a host to both parts of the industry. For every large branded drug player, there are generic makers here. Ireland’s improved competitiveness in recent years has also made it possible for IDA to compete for and win investments from generic manufacturers, such as Mylan’s recent investment.
June 11, 2012